NEWS & EVENTS
Rivaroxaban receives licence in the UK
Rivaroxaban (Xarelto) receives licence in the UK for prevention of stroke in atrial fibrillation and the treatment of deep vein thrombosis and pulmonary embolism
Major report on Atrial Fibrillation launched by ACE.
A major source of information for patients and healthcare professionals on all aspects of AF, including urgent actions needed now to prevent untreated AF from causing a stroke epidemic.
Read the AF Report
Calculate your personal risk of stroke because of AF
Information for patients taking warfarin
Have you recently been prescribed warfarin and would like more information? For a beginners guide to warfarin please watch this short video. Video kindly created by Southampton University NHS Hospital Foundation Trust
WELCOME TO ANTICOAGULATION EUROPE
INREVIEW MAGAZINE
We rely on donations and subscriptions so please consider joining or making a donation to enable us to coninue our work.
You can donate by clicking on to the link to right of this page. For easy ways to help us raise funds click on news then fundraising.
Home insurance, protect what makes your house a home.
Read more.
